N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors

N-Succinyl-chitosan (NSC) was synthesized and NSC nanoparticles (NPs) with loaded osthole (Ost) (Ost/NSC-NPs) were prepared by emulsion solvent diffusion. Subsequently, low-density lipoprotein (LDL)-mediated NSC-NPs with loaded Ost (Ost/LDL-NSC-NPs) were obtained by coupling LDL with Ost/NSC-NPs through amide linkage. The average particle size of Ost/NSC-NPs was approximately 145 nm, the entrapment efficiency was 78.28%±2.06%, and the drug-loading amount was 18.09%±0.17%. The release of Ost from Ost/NSC-NPs in vitro showed a more evident sustained effect than the native material. The half maximal inhibitory concentration of Ost/LDL-NSC-NPs was only 16.23% that of the free Ost at 24 hours in HepG2 cells. Ost inhibited HepG2 cell proliferation by arresting cells in the synthesis phase of the cell cycle and by triggering apoptosis. Cellular uptake and subcellular localization in vitro and near-infrared fluorescence real-time imaging in vivo showed that Ost/LDL-NSC-NPs had high targeting efficacy. Therefore, LDL-NSC-NPs are a promising system for targeted Ost delivery to liver tumor.

[1]  Aiqin Wang,et al.  Adsorption properties of N-succinyl-chitosan and cross-linked N-succinyl-chitosan resin with Pb(II) as template ions , 2006 .

[2]  Xin Huang,et al.  A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs , 2006, Science.

[3]  H. Zhen,et al.  Neuroprotective effects of osthole pretreatment against traumatic brain injury in rats , 2012, Brain Research.

[4]  A. Fischer,et al.  Gene therapy for severe combined immunodeficiency. , 2005, Annual review of medicine.

[5]  Keming Chen,et al.  Osthol, a Coumarin Isolated from Common Cnidium Fruit, Enhances the Differentiation and Maturation of Osteoblasts in vitro , 2011, Pharmacology.

[6]  T. Nagai,et al.  Pharmacokinetic characteristics and antitumor activity of the N-succinyl-chitosan-mitomycin C conjugate and the carboxymethyl-chitin-mitomycin C conjugate. , 1993, Biological & pharmaceutical bulletin.

[7]  R. Firestone,et al.  Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. , 1994, Bioconjugate chemistry.

[8]  Shun-Fa Yang,et al.  Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression. , 2012, Toxicology and applied pharmacology.

[9]  F. Zhao,et al.  Interactions between N-succinyl-chitosan and bovine serum albumin , 2007 .

[10]  Yong-yan Bei,et al.  Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for osthole , 2013, International journal of nanomedicine.

[11]  T. Nagai,et al.  Synthesis and drug-release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin. , 1992, Chemical & pharmaceutical bulletin.

[12]  Hyesung Jeon,et al.  Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[13]  J. Bruix,et al.  Prognostic assessment and evaluation of the benefits of treatment. , 2002, Journal of clinical gastroenterology.

[14]  Qing-jiu Tang,et al.  Effects of Osthole on Migration and Invasion in Breast Cancer Cells , 2010, Bioscience, biotechnology, and biochemistry.

[15]  Zhi Ding,et al.  Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. , 2003, International journal of pharmaceutics.

[16]  P. Opanasopit,et al.  Incorporation methods for cholic acid chitosan-g-mPEG self-assembly micellar system containing camptothecin. , 2009, Colloids and surfaces. B, Biointerfaces.

[17]  T. Chandy,et al.  5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. , 2000, Journal of microencapsulation.

[18]  Yi Zhang,et al.  Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway , 2011, Journal of experimental & clinical cancer research : CR.

[19]  Miqin Zhang,et al.  Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. , 2009, Cancer research.

[20]  T. Südhof,et al.  The LDL receptor gene: a mosaic of exons shared with different proteins. , 1985, Science.

[21]  Yu-Chih Liang,et al.  Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice. , 2009, Chemico-biological interactions.

[22]  V. Schumaker,et al.  Sequential flotation ultracentrifugation. , 1986, Methods in enzymology.

[23]  C. Hsieh,et al.  Osthole improves aspects of spatial performance in ovariectomized rats. , 2004, The American journal of Chinese medicine.

[24]  A. Befeler,et al.  Hepatocellular carcinoma: diagnosis and treatment. , 2002, Gastroenterology.

[25]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  K. Ueno,et al.  Inhibitory effect of oxycoumarins isolated from the Thai medicinal plant Clausena guillauminii on the inflammation mediators, iNOS, TNF-α, and COX-2 expression in mouse macrophage RAW 264.7 , 2008, Journal of Natural Medicines.

[27]  D. Mishra,et al.  Chitosan nanoparticles: a promising system in novel drug delivery. , 2010, Chemical & pharmaceutical bulletin.

[28]  S. Yoshida,et al.  Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas. , 2005, Current medicinal chemistry. Anti-cancer agents.